INTERNATIONAL PATENT: NEURELIS, INC. FILES APPLICATION FOR "INTRANASAL OLANZAPINE FORMULATIONS AND METHODS OF THEIR USE"

GENEVA, July 30 -- NEURELIS, INC. (3430 Carmel Mountain RoadSuite 300San Diego, California 92121) filed a patent application (PCT/US2025/011924) for "INTRANASAL OLANZAPINE FORMULATIONS AND METHODS OF THEIR USE" on Jan 16, 2025. With publication no. WO/2025/155754, the details related to the patent application was published on Jul 24, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MADDEN, Stuart (c/o Neurelis, Inc.3430 Carmel Mountain RoadSuite 300San Diego, California 92121)

Abstract: Compositions for intranasal delivery of olanzapine and methods for their use to treat various symptoms o...